| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 03/06/2002 | CN1080257C Guanidine derivatives |
| 03/05/2002 | US6352839 Preparing virginiamycins from an engineered microorganisms, having the ability to prevent biosynthesis of the precursor antibiotic; the microorganism is cultured in the presence of a second precursor and the streptogramin analog is recovered |
| 02/28/2002 | WO2002016368A1 Process for the preparation and purification of thiol-containing maytansinoids |
| 02/28/2002 | WO2001030782A3 Novel herbicides |
| 02/28/2002 | WO2000040569A9 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 02/28/2002 | US20020026047 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation |
| 02/28/2002 | US20020026032 3, 5-Dioxa-12-azawurtzitane compound and process of preparing same |
| 02/28/2002 | US20020025959 Heterocycle carboxamides as antiviral agents |
| 02/28/2002 | US20020025956 Nervous system, psychological disorders |
| 02/28/2002 | US20020025910 3-heterocycly1 - substituted benzoyl derivatives |
| 02/28/2002 | DE10040525A1 New 6-acylamino-4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors or respiratory or gastrointestinal diseases |
| 02/28/2002 | CA2678754A1 Process for the preparation and purification of thiol-containing maytansinoids |
| 02/27/2002 | EP1182202A1 Aminomethylpyrrolidine derivatives having aromatic substituents |
| 02/27/2002 | EP1181938A2 Rapamycin conjugates and antibodies |
| 02/27/2002 | EP1181295A2 Tricyclic benzoylcyclohexanedione derivatives |
| 02/27/2002 | EP1181282A2 Benzothiazinone and benzoxazinone compounds |
| 02/27/2002 | EP1181279A1 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
| 02/27/2002 | CN1337962A Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors |
| 02/26/2002 | US6351328 Variable transmittance electrochromic devices |
| 02/26/2002 | US6350755 Peptidomimetic compounds that do not have a thiol moiety; therapy of arteriosclerosis and diabetic vascular pathologies; |
| 02/26/2002 | US6350745 Thrombin inhibitors |
| 02/26/2002 | CA2128119C Benzospiroalkene derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/26/2002 | CA2012978C Treatment of hepatic diseases using fk 506 and related compounds |
| 02/21/2002 | WO2002014536A2 Odulating multiple lineage kinase proteins |
| 02/21/2002 | WO2002014271A1 Proline derivatives and use thereof as drugs |
| 02/21/2002 | WO2001058904A9 Apoptosis-inducing compounds |
| 02/21/2002 | WO2001058869B1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 02/21/2002 | US20020022636 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 02/21/2002 | US20020022633 Inhibitors of prenyl-protein transferase |
| 02/21/2002 | US20020022620 Reverse-turn mimetics and methods relating thereto |
| 02/21/2002 | CA2419985A1 Modulating multiple lineage kinase proteins |
| 02/20/2002 | CN1336930A Bridged heterocyclic derivatives |
| 02/20/2002 | CN1336922A Hypolipidemic and antioxidant morpholine derivatives |
| 02/19/2002 | USRE37556 Superoxide radical inhibitor |
| 02/19/2002 | US6348457 Antagonizing reserpine in mammals |
| 02/14/2002 | WO2002012442A2 Heterocyclic compounds as ligands of the gabaa receptor |
| 02/14/2002 | WO2002012230A1 Intermediate of carbapenem antibiotics and process for the preparation thereof |
| 02/14/2002 | WO2002011766A2 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation |
| 02/14/2002 | WO2002011733A1 Pharmaceutical composition comprising condensed indole compound |
| 02/14/2002 | WO2001055119A3 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/14/2002 | US20020019429 Antiarthritic agents; osteoporosis |
| 02/14/2002 | US20020019386 5-HT4 receptor antagonists |
| 02/14/2002 | US20020018912 Transistors, liquid crystal display, electrooptics |
| 02/14/2002 | CA2420967A1 Heterocyclic compounds as ligands of the gabaa receptor |
| 02/14/2002 | CA2418904A1 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation |
| 02/13/2002 | EP0861250B1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase |
| 02/12/2002 | US6346536 Benzopyranoisoquinolone derivatives; neurodegenerative and brain disorders; reperfusion injuries; antiischemic agents |
| 02/12/2002 | US6346531 G-CSF mimetics |
| 02/12/2002 | CA2024399C Compounds |
| 02/07/2002 | WO2002010174A1 Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b][1,3]benzotiazepines |
| 02/07/2002 | WO2002010172A1 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 02/07/2002 | WO2002010148A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 02/07/2002 | WO2002010139A1 Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase |
| 02/07/2002 | WO2001074823A3 Fused heterocyclic derivatives, their production and use |
| 02/07/2002 | US20020016625 Drug/drug delivery systems for the prevention and treatment of vascular disease |
| 02/07/2002 | CA2417788A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 02/07/2002 | CA2415851A1 Hexahydro-7-1h-azepin-2-yl-haxanoic acid derivatives as inhibitors of inducible nitric oxide synthase |
| 02/06/2002 | CN1334812A Piperazine derivatives |
| 02/06/2002 | CN1334702A Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 02/05/2002 | CA2050623C Ointments containing tricyclic compound |
| 01/31/2002 | WO2002008231A2 Biologically active macrolides, compositions, and uses thereof |
| 01/31/2002 | US20020013461 Corticotropin releasing factor antagonist |
| 01/31/2002 | US20020013335 Method of treating cardiovascular disease |
| 01/31/2002 | US20020013325 Useful as glycoprotein IIb/IIIa antagonists for prophylaxis thrombosis, therapy of atheroschlerosis, arterioschlerosis, acute myocardial infarction, chronic stable angina, unstable angina, transient ischemic attacks and strokes |
| 01/31/2002 | DE10034625A1 New aryl substituted thienyl-oxazolidinone derivatives useful as tumor necrosis factor-alpha inhibitors in treatment of e.g. atherosclerosis, arthritis, Crohn's disease, osteoporosis, transplant rejection and psoriasis |
| 01/30/2002 | EP1175422A2 Tetracyclic progesterone receptor modulator compounds and methods |
| 01/30/2002 | CN1333820A Recombinant methods and materials for producing epothilone and eopthilone derivatives |
| 01/30/2002 | CN1333765A Cycloalkyl-substituted aminomethylpyrrolidine derivatives |
| 01/30/2002 | CN1333758A Substituted bicyclic derivatives useful as anticancer agents |
| 01/29/2002 | US6342507 Antibiotics, antiinflammatory agents |
| 01/29/2002 | CA2092330C Novel alkylenediammonium diclavulanate derivatives, a process for the preparation thereof as well as the use thereof |
| 01/24/2002 | WO2002006296A1 Processes for the preparation of 2,2'-anhydronucleic acid compound derivatives |
| 01/24/2002 | WO2001058869A3 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 01/24/2002 | US20020010328 Genetic engineering |
| 01/23/2002 | EP1173443A1 Cyclic urea and cyclic amide derivatives |
| 01/23/2002 | EP1173440A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
| 01/23/2002 | EP1173255A2 Use of pirenoxine for the protection of corneal tissues in photokeratectomy |
| 01/23/2002 | EP1173253A1 Contraceptive compositions containing cyclic carbamates and amide derivatives |
| 01/23/2002 | EP1173208A2 Contraceptive compositions containing cyclic urea and amide derivatives |
| 01/23/2002 | EP1173177A1 Use of macrolide compounds for the treatment of dry eye |
| 01/23/2002 | EP0711292B1 Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity |
| 01/23/2002 | CN1332743A Cell adhesion-inhibiting antinflammatory compounds |
| 01/22/2002 | US6340760 Process for the preparation of (S)-N-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxyamide |
| 01/22/2002 | US6340680 Oxazinoquinolones useful for the treatment of viral infections |
| 01/22/2002 | CA2028909C Preparation of intermediates and the synthesis of n-(2-hydroxy-ethyl)-2-hydroxymethyl-3,4,5-trihydroxypiperidines |
| 01/17/2002 | WO2002004465A1 Methods and kits for the detection of arginine compounds |
| 01/17/2002 | WO2002004462A1 Oxazinoquinolones useful for the treatment of viral infections |
| 01/17/2002 | WO2002004445A1 Heterocycle carboxamides as antiviral agents |
| 01/17/2002 | WO2002004409A2 Tetrahydrobenzothiazole analogues as neuroprotective agents |
| 01/17/2002 | WO2002004402A1 Ester derivatives |
| 01/17/2002 | US20020007059 Potassium channel modulators relax smooth muscle cells and inhibit bladder contractions; treating nervous, eating, cardiovascular, gastrointestinal, and sexual disorders |
| 01/17/2002 | US20020006923 Thrombin inhibitors |
| 01/17/2002 | CA2415815A1 Tetrahydrobenzothiazole analogues as neuroprotective agents |
| 01/17/2002 | CA2415468A1 Ester derivatives |
| 01/17/2002 | CA2415174A1 Methods and kits for the detection of arginine compounds |
| 01/16/2002 | EP1171432A1 Adamantane derivatives |
| 01/16/2002 | CN1331694A Antihistaminic spiro compounds |
| 01/16/2002 | CN1331691A Piperidines as CCR5 modulators |
| 01/16/2002 | CN1331591A Piperidines as CCR5 modulators |
| 01/16/2002 | CN1077886C Amidino derivatives useful as nitric oxide synthase inhibitors |